279 related articles for article (PubMed ID: 10926943)
21. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
22. Who is ineligible for warfarin in atrial fibrillation?
Verheugt FW
Lancet; 2009 Aug; 374(9689):510-1. PubMed ID: 19683630
[No Abstract] [Full Text] [Related]
23. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
24. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry.
Lopes RD; Shah BR; Olson DM; Zhao X; Pan W; Bushnell CD; Peterson ED
Stroke; 2011 Dec; 42(12):3477-83. PubMed ID: 21903948
[TBL] [Abstract][Full Text] [Related]
26. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
27. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
[TBL] [Abstract][Full Text] [Related]
28. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
29. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
30. Outcomes associated with combined antiplatelet and anticoagulant therapy.
Johnson SG; Rogers K; Delate T; Witt DM
Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
[TBL] [Abstract][Full Text] [Related]
31. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Lalouschek W; Lang W; Müllner M;
Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
[TBL] [Abstract][Full Text] [Related]
32. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
Hankey GJ
Curr Opin Neurol; 2010 Feb; 23(1):65-72. PubMed ID: 19949330
[TBL] [Abstract][Full Text] [Related]
33. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
34. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.
Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H;
Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Lee MS; Smith SD; Galor A; Hoffman GS
Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
[TBL] [Abstract][Full Text] [Related]
36. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Thompson PL; Verheugt FW
Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
[TBL] [Abstract][Full Text] [Related]
37. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR;
Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682
[TBL] [Abstract][Full Text] [Related]
38. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
[TBL] [Abstract][Full Text] [Related]
39. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
[TBL] [Abstract][Full Text] [Related]
40. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Kamath S; Blann AD; Chin BS; Lip GY
J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
